On March 30, 2022, the California Division of Workers’ Compensation (DWC) ordered an update to the Pathology and Clinical Laboratory section of the Official Medical Fee Schedule (OMFS), bringing the OMFS in line with Medicare’s 2022 second quarter changes to reimbursement.
The update deletes 2 billing codes and adds 18 new billing codes; the reimbursement rate for all the new codes is $0.00.
Additionally, the order maintains prices set at 120% of Medicare rates for COVID-19-related testing codes, one of which was altered by a subsequent update to Medicare’s second quarter changes.
This update is retroactive to dates of service rendered on or after April 1, 2022.
Per California Labor Code Section 5307.1, the DWC order (announced in a recent Newsline) incorporates by reference Medicare’s April 2022 quarterly update to its Clinical Laboratory Fee Schedule. OMFS reimbursement for Pathology and Clinical Laboratory services is set at 120% of the applicable fees in the Medicare electronic file “22LABQ2_0,” which Medicare subsequently revised on March 31, 2022.
The order also maintains COVID-19-related testing codes and prices set at 120% of the price set by the California Medicare Administrative Contractor Noridian. Medicare’s March 31 revision to the 22CLABQ2_0 file decreases the reimbursement for one proprietary laboratory analysis code, as follows:
Procedure Code |
Description |
OMFS Reimbursement 4/1/2022 |
OMFS Reimbursement 1/1/2022 |
Reimbursement Difference |
0108U |
Gi barrett esoph 9 prtn bmrk |
$2,820.00 |
$3,015.90 |
-$195.90 |
The newly added and deleted Pathology and Clinical Laboratory procedure codes are outlined below.
New Procedure Code |
Description |
OMFS Reimbursement |
0306U |
Onc mrd nxt-gnrj alys 1st |
$0.00 |
0307U |
Onc mrd nxt-gnrj alys sbsq |
$0.00 |
0308U |
Crd cad alys 3 prtn plsm alg |
$0.00 |
0309U |
Crd cv ds aly 4 prtn plm alg |
$0.00 |
0310U |
Ped vsclts kd alys 3 bmrks |
$0.00 |
0311U |
Nfct ds bct quan antmcrb sc |
$0.00 |
0312U |
Ai ds sle alys 8 igg autoant |
$0.00 |
0313U |
Onc pncrs dna&mrna seq 74 |
$0.00 |
0314U |
Onc cutan mlnma mrna 35 gene |
$0.00 |
0315U |
Onc cutan sq cll ca mrna 40 |
$0.00 |
0316U |
B brgdrferi lyme ds ospa evl |
$0.00 |
0317U |
Onc lung ca 4-prb fish assay |
$0.00 |
0318U |
Ped whl gen mthyltn alys 50+ |
$0.00 |
0319U |
Neph rna pretrnspl perph bld |
$0.00 |
0320U |
Neph rna psttrnspl perph bld |
$0.00 |
0321U |
Iadna gu pthgn 20bct&fng org |
$0.00 |
0322U |
Neuro asd meas 14 acyl carn |
$0.00 |
Deleted Procedure Code |
Description |
Former OMFS Reimbursement |
0097U |
Gi pathogen 22 targets |
$435.64 |
0151U |
Nfct bct/vir resp nfctj 33 |
$229.32 |
DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.